Trial Information

Summary: A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

Status: Recruiting

Protocol Number: BO19373

Sponsor: Hoffmann-La Roche

Company Division: Pharmaceutical

Official Scientific Title: A dose-escalation study of R1507 in patients with advanced solid tumors.

Brief Summary: This study will determine the maximum tolerated dose and pharmacokinetic profile of R1507 in patients with metastatic or locally advanced malignant solid tumors, non-Hodgkin's lymphoma or Hodgkin's lymphoma. Groups of patients will be sequentially enrolled to receive ascending doses of R1507 either weekly or three-weekly by intravenous infusion. The starting dose of 1mg/kg iv for each dosing regimen will be escalated in subsequent groups of patients after a satisfactory assessment of safety, tolerability and pharmacokinetics of the previous dose. The anticipated time on study treatment is until disease progression or dose-limiting toxicity, and the target sample size is <100 individuals. Target sample size is 93.

Study Phase: I

Study Design / Study Details:

• Purpose: Treatment
• Allocation: Non-Randomized
• Masking: Open Label
• Control: Uncontrolled
• Assignment: Single Group
• Endpoints: Safety

Study Type:

Condition: Neoplasms

Intervention Type: Drug

Intervention Name: R1507

Primary Outcome: 1. AEs, laboratory parameters, Cmax, Tmax, AUC, clearance, Vdss elimination half life Time frame: Throughout study

Key Secondary Outcomes: 1. Tumor response Time frame: Event driven

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 18 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: April, 2006

Trial Registration Date: 11/16/2006

Date Last Updated: 06/17/2008

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 7, 2008 at 2:31:15 PM